Tue, 19 May 2026
Hunch
UK takeovers30 Sep 2026

Vesuvius's biggest shareholder backs a 549p offer. Will the board agree?

RHI Magnesita said on 29 September it is in talks to buy Vesuvius for 549p a share. Cevian, which owns 23%, will back it if the board does.

5 min read

What happened

On RHI Magnesita said it may make an offer for Vesuvius worth 549p a share, and Cevian, owner of 23% of Vesuvius, promised to support it if the Vesuvius board recommends it.

RHI Magnesita has offered 549p a share for Vesuvius: 470p in cash plus about 0.028 new RHI Magnesita shares. That is 47% above the Vesuvius share price on . Vesuvius shareholders would also keep a 7.1p interim dividend, and they would own about 13% of the combined company. RHI Magnesita made the proposal on and made it public on .

Cevian, a shareholder since 2012 and the largest with 23%, has promised in writing to support the deal with all its shares if the Vesuvius board recommends it. The promise ends if there is no recommended offer by , if a rival offer comes, or if RHI Magnesita walks away.

The Vesuvius board has turned RHI Magnesita down many times in the past year. It rejected 448p in cash on and several more proposals up to December. It rejected 550p in cash on and a mix of cash and shares worth about 550p in June.

This time the board has not said no. Vesuvius spoke after reports in the press and said it is carefully weighing the price and the risk that the deal cannot be completed. It told shareholders to take no action for now. RHI Magnesita says its loans and the work for regulators’ approvals are well prepared.

Under UK takeover rules RHI Magnesita must make a firm offer or walk away by 5pm on . The Takeover Panel can move that date if the Vesuvius board asks.

Sources: Vesuvius (2)

The Pattern

We looked for cases where a company’s board had refused a buyer at least twice, and then the company’s largest shareholder, not a buyer itself, came out in public for the buyer before the board had agreed. We found five since 2004, in Britain, France, Germany and South Africa. In two of them the board went on to recommend the offer.

2 of 5
In 2 of 5 cases the board recommended the offer, and in both the buyer raised its price. In the other three the board never backed the deal.
2020 Suez, Veoliaheld
: Engie sold its 29.9% of Suez to Veolia at €18 a share. Veolia said it would not bid for the rest without the Suez board’s approval. On both boards agreed a price of €20.50. (Veolia)
2017 Uniper, Fortumnot held
: E.ON agreed to sell its 46.65% of Uniper into Fortum’s offer. On Uniper’s boards told shareholders not to accept. Fortum kept its price and ended with 47.35%. (Fortum)
Show the other 3 cases
2015 SABMiller, AB InBevheld
: after the board had refused AB InBev three times, Altria, owner of 27%, backed its £42.15 offer and urged talks. Six days later the board said it would recommend £44 a share. (SABMiller and AB InBev)
2005 Manchester United, Glazernot held
: after the board refused three proposals from Malcolm Glazer, Cubic Expression sold him its stake of about 29%. He took control at 300p a share without the board’s backing or a higher price. (NBC News)
2004 Gold Fields, Harmonynot held
: Norilsk, owner of 20.03% of Gold Fields, agreed to accept Harmony’s offer. The board told shareholders to take no action, and on a court ruled the offer had lapsed. (Gold Fields (SEC filing))

The Read

History is split. In two of five cases the board went on to recommend the offer, and both times the buyer paid more. In both, the shareholder had left the final word to the board: Altria urged SABMiller to talk, and Veolia promised not to bid for Suez without the board. Cevian’s promise works the same way, since it counts only if the Vesuvius board recommends. In the other three the shareholder sold its shares or agreed to accept directly, and the board never backed the deal.

Timing is the weak point. Only SABMiller ran under the same British 28-day deadline, and its board agreed six days after Altria spoke. The Vesuvius board has had the August proposal for a month and is still weighing it. Its price is about the same 550p it rejected in March and June. Cevian’s promise ends on without a recommended offer.

A recommendation, a higher offer or a longer deadline would each be announced on the London Stock Exchange news service. A new rejection from the board, or RHI Magnesita walking away, would end all three questions early.

Disclaimer

Hunch works only from sources that are publicly available, and publishes on the basis of analysis of that material. We do not form an editorial opinion or take sides, we give a simpler and wider view of news that already exists. If information in a source we used was inaccurate, distorted, or later disputed but had already entered our analysis, Hunch accepts no liability for that. Predictions are not advice. Phase 1 markets use Hunch Points, not money.

Published by Hunch under the Editorial Code. Complaints and corrections: /contact/.

Comment

Comments are moderated. Members post under their prediction record.